<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-WE8VRNP5</identifier><date>2015</date><creator>Mannemala, Sai Sandeep</creator><creator>Nagappan, Kannappan</creator><creator>Subramanian, Venkatesan</creator><relation>documents/doc/W/URN_NBN_SI_doc-WE8VRNP5_001.pdf</relation><relation>documents/doc/W/URN_NBN_SI_doc-WE8VRNP5_001.txt</relation><format format_type="issue">3</format><format format_type="volume">62</format><format format_type="type">article</format><format format_type="extent">str. 633-641</format><identifier identifier_type="ISSN">1318-0207</identifier><identifier identifier_type="COBISSID">283046400</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-WE8VRNP5</identifier><language>eng</language><publisher>Slovensko kemijsko društvo</publisher><source>Acta chimica slovenica</source><rights>BY</rights><subject language_type_id="slv">analizne metode</subject><subject language_type_id="slv">fenobarbiton</subject><subject language_type_id="slv">HPLC-PDA</subject><subject language_type_id="slv">spironolakton</subject><subject language_type_id="slv">tekočinska kromatografija</subject><subject language_type_id="slv">torasemid</subject><title>Optimization and validation of a sensitive method for HPLC-PDA simultaneous determination of torasemide and spironolactone in human plasma using central composite design</title></Record>